Skip to main content
Year archive

ADHERIUM LIMITED — 2022 filings

All 96 regulatory filings released by ADHERIUM LIMITED (ADR) in 2022, sourced directly from the official regulator.

96 Filings
2022 Period
2022 filings (96)
Filing Released Lang
Ceasing to be a substantial holder 7 pages 128.4KB
Major Shareholding Notification
2022-12-13 English
Cleansing notice under s708A of the Corporations Act 1
Regulatory Filings
2022-12-12 English
Change of Director's Interest Notice (G Baran) 3 pages 158.8KB
Director's Dealing
2022-12-12 English
Change in substantial holding (Trudell Medical) 2 pages 413.3KB
Regulatory Filings
2022-12-12 English
Application for quotation of securities - ADR 6 pages 27.6KB
Capital/Financing Update
2022-12-11 English
Notification regarding unquoted securities - ADR 5 pages 26.4KB
Share Issue/Capital Change
2022-12-11 English
Application for quotation of securities - ADR 6 pages 27.9KB
Share Issue/Capital Change
2022-12-11 English
Notification regarding unquoted securities - ADR 5 pages 26.8KB
Share Issue/Capital Change
2022-12-11 English
Adherium Share Purchase Plan Offer Results 2 pages 111.5KB
Capital/Financing Update
2022-12-08 English
Application for quotation of securities - ADR 7 pages 30.1KB
Share Issue/Capital Change
2022-12-07 English
Final Director's Interest Notice 2 pages 124.2KB
Director's Dealing
2022-12-01 English
Adherium receives $1.3m Australian R&D Tax Incentive 2 pages 112.6KB
Capital/Financing Update
2022-12-01 English
CEO's Address to Shareholders at AGM 8 pages 343.9KB
AGM Information
2022-11-29 English
Results of Meeting and Director Update 2 pages 301.3KB
Declaration of Voting Results & Voting Rights Announcements
2022-11-29 English
US FDA clearance of Adherium's Hailie for GSK inhalers 4 pages 365.6KB
Regulatory Filings
2022-11-27 English
Adherium exhibiting at 2022 BTS Winter Meeting 2 pages 108.2KB
Regulatory Filings
2022-11-23 English
Adherium SPP and Shortfall Offers Prospectus 41 pages 1.1MB
Capital/Financing Update
2022-11-16 English
Update - Proposed issue of securities - ADR 6 pages 31.6KB
Capital/Financing Update
2022-11-15 English
Update - Proposed issue of securities - ADR 6 pages 30.4KB
Capital/Financing Update
2022-11-15 English
Adherium Exhibiting at ACAAI 2022 2 pages 106.2KB
Regulatory Filings
2022-11-10 English
Becoming a substantial holder 9 pages 321.0KB
Major Shareholding Notification
2022-11-06 English
Change of Director's Interest Notice (G Baran) 3 pages 158.4KB
Director's Dealing
2022-11-03 English
Change of Director's Interest Notice (L Panaccio) 2 pages 155.8KB
Director's Dealing
2022-11-03 English
Change in substantial holding 2 pages 396.8KB
Regulatory Filings
2022-11-02 English
Change in substantial holding 2 pages 289.1KB
Major Shareholding Notification
2022-11-02 English
Change in substantial holding 2 pages 89.5KB
Major Shareholding Notification
2022-11-01 English
Disclosure of Long Equity Derivative Positions 2 pages 280.2KB
Major Shareholding Notification
2022-11-01 English
Notice of Annual General Meeting/Proxy Form 71 pages 1.4MB
AGM Information
2022-10-31 English
Becoming a substantial holder 3 pages 142.8KB
Major Shareholding Notification
2022-10-30 English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 381.0KB
Interim / Quarterly Report Q1 2023
2022-10-27 English
Application for quotation of securities - ADR 6 pages 27.6KB
Share Issue/Capital Change
2022-10-27 English
Notification of cessation of securities - ADR 4 pages 24.2KB
Regulatory Filings
2022-10-27 English
Ceasing to be a substantial holder 1 page 222.0KB
Major Shareholding Notification
2022-10-27 English
Notification regarding unquoted securities - ADR 5 pages 26.4KB
Share Issue/Capital Change
2022-10-27 English
Cleansing notice under s708A of the Corporations Act 1
Capital/Financing Update
2022-10-27 English
CEO Presentation to EGM 11 pages 1.2MB
Investor Presentation
2022-10-20 English
Results of Meeting 2 pages 405.5KB
Declaration of Voting Results & Voting Rights Announcements
2022-10-20 English
ADR to present at Australian Microcap Investment Conference 2 pages 106.3KB
Investor Presentation
2022-10-12 English
Notification of cessation of securities - ADR 4 pages 24.3KB
Regulatory Filings
2022-10-04 English
Notice Required under ASX Listing Rule 3.13.1 1 pag
AGM Information
2022-10-04 English
Change in substantial holding 3 pages 230.0KB
Major Shareholding Notification
2022-10-02 English
Appendix 4G 13 pages 301.7KB
Regulatory Filings
2022-09-29 English
Corporate Governance Statement 2022 13 pages 238.1KB
Governance Information
2022-09-29 English
Annual Report to shareholders 62 pages 5.7MB
Regulatory Filings
2022-09-29 English
Change in substantial holding 2 pages 288.5KB
Major Shareholding Notification
2022-09-29 English
Becoming a substantial holder 3 pages 88.5KB
Major Shareholding Notification
2022-09-27 English
Change in substantial holding 3 pages 328.6KB
Major Shareholding Notification
2022-09-26 English
Application for quotation of securities - ADR 6 pages 27.6KB
Share Issue/Capital Change
2022-09-25 English
Cleansing notice under s708A of the Corporations Act 1
Capital/Financing Update
2022-09-25 English
Adherium appoints Daniel Kaplon as Chief Financial Officer 2 pages 104.6KB
Board/Management Information
2022-09-20 English
Notice of Extraordinary General Meeting/Proxy Form 22 pages 632.5KB
AGM Information
2022-09-20 English
New Hailie sensors to be used in US clinical study 2 pages 110.9KB
Regulatory Filings
2022-09-19 English
Adherium secures $13.5m in placement commitments 5 pages 211.5KB
Capital/Financing Update
2022-09-15 English
Proposed issue of securities - ADR 5 pages 27.5KB
Capital/Financing Update
2022-09-15 English
Proposed issue of securities - ADR 5 pages 27.7KB
Capital/Financing Update
2022-09-15 English
Proposed issue of securities - ADR 6 pages 30.6KB
Capital/Financing Update
2022-09-15 English
Proposed issue of securities - ADR 6 pages 32.0KB
Capital/Financing Update
2022-09-15 English
Proposed issue of securities - ADR 6 pages 29.9KB
Capital/Financing Update
2022-09-15 English
Proposed issue of securities - ADR 5 pages 27.8KB
Capital/Financing Update
2022-09-15 English
Proposed issue of securities - ADR 6 pages 29.9KB
Capital/Financing Update
2022-09-15 English
Trading Halt 2 pages 294.9KB
Capital/Financing Update
2022-09-13 English
Adherium to integrate Hailie into CareCentra AI platform 3 pages 114.3KB
Regulatory Filings
2022-09-12 English
Adherium and Dulcian Health patient monitoring integration 3 pages 112.8KB
Regulatory Filings
2022-09-08 English
Preliminary Final Report 12 pages 372.4KB
Annual Report FY 2022
2022-08-30 English
Application for quotation of securities - ADR 7 pages 29.5KB
Share Issue/Capital Change
2022-08-28 English
Adherium submits US FDA application for Hailie for Teva MDIs 2 pages 112.7KB
Regulatory Filings
2022-08-24 English
Adherium to present at Reach Markets webinar 2 pages 107.3KB
Investor Presentation
2022-08-15 English
Adherium Investor Update Presentation August 2022 18 pages 1.6MB
Investor Presentation
2022-08-07 English
Details of Company Address - Principal Administrative Office 1
Regulatory Filings
2022-08-04 English
Adherium submits US FDA application for Hailie for GSK pMDIs 3 pages 120.0KB
Regulatory Filings
2022-08-01 English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 404.7KB
Interim / Quarterly Report Q4 2022
2022-07-27 English
Adherium receives US FDA clearance for Hailie for Ellipta 4 pages 210.8KB
Regulatory Filings
2022-07-24 English
Adherium signs US distribution agreement with Perigon Health 2 pages 152.7KB
Capital/Financing Update
2022-07-19 English
Adherium signs UK distribution agreement with Helicon Health 2 pages 109.5KB
Capital/Financing Update
2022-06-13 English
Adherium to support Avillion sponsored clinical study 3 pages 135.2KB
Regulatory Filings
2022-06-01 English
Adherium Senior Management Update 2 pages 109.2KB
Board/Management Information
2022-05-29 English
Adherium Exhibiting at ATS 2022 2 pages 106.4KB
Regulatory Filings
2022-05-12 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 351.4KB
Interim / Quarterly Report Q3 2022
2022-04-28 English
Adherium Releases Next Gen Platform Integration Services 3 pages 249.9KB
Capital/Financing Update
2022-04-27 English
Adherium appoints VP of Global Business Development 3 pages 112.3KB
Board/Management Information
2022-04-21 English
Notification of cessation of securities - ADR 4 pages 24.2KB
Share Issue/Capital Change
2022-04-06 English
Adherium submits US FDA application for Ellipta sensor 2 pages 131.8KB
Regulatory Filings
2022-03-06 English
Initial Director's Interest Notice - L Panaccio 2 pages 124.6KB
Director's Dealing
2022-03-01 English
Final Director's Interest Notice - M McNamara 2 pages 125.3KB
Director's Dealing
2022-03-01 English
Cleansing notice under s708A of the Corporations Act 1
Capital/Financing Update
2022-03-01 English
Lou Panaccio joins Adherium Board - Matt McNamara steps down 3 pages 119.0KB
Board/Management Information
2022-02-24 English
Half Yearly Report and Accounts 22 pages 5.4MB
Regulatory Filings
2022-02-24 English
Application for quotation of securities - ADR 7 pages 30.0KB
Share Issue/Capital Change
2022-02-23 English
Notification of cessation of securities - ADR 4 pages 24.3KB
Regulatory Filings
2022-02-22 English
US Respiratory RPM and RTM Reimbursement Rates 4 pages 128.1KB
Capital/Financing Update
2022-02-20 English
Manufacturing started for physiological parameters sensors 3 pages 150.4KB
Regulatory Filings
2022-02-10 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 372.7KB
Interim / Quarterly Report Q2 2022
2022-01-27 English
Adherium receives MHRA Registration confirmation 2 pages 127.1KB
Regulatory Filings
2022-01-23 English
Adherium receives $1.6m Australian R&D Tax Incentive 2 pages 117.0KB
Regulatory Filings
2022-01-18 English
Notification of cessation of securities - ADR 4 pages 24.6KB
Transaction in Own Shares
2022-01-17 English
U.S. Remote Therapeutic Monitoring Codes Finalised 4 pages 124.3KB
Regulatory Filings
2022-01-12 English